September 2022 Issue: Mirati Therapeutics (SYM: MRTX)
- Dylan Jovine
- Wednesday, September 21, 2022
Today I want to talk to you about KRAS mutations in cancer treatment. But first, we have three stocks to sell today. We’ll be taking profits on two and a loss on one.
UPDATE: Rhythm Pharmaceuticals (SYM: RYTM) Up 135%
- Dylan Jovine
- Thursday, July 14, 2022
A quick update and share some exciting news about one of our “Strong Buy” recommendations, Rhythm Pharmaceuticals (RYTM).
June 2021 Issue: Not all Obesity is the Same -Rhythm Pharmaceuticals
- Dylan Jovine
- Monday, June 21, 2021
September 2022 Issue: Mirati Therapeutics (SYM: MRTX)
- Dylan Jovine
- Wednesday, September 21, 2022
Today I want to talk to you about KRAS mutations in cancer treatment. But first, we have three stocks to sell today. We’ll be taking profits on two and a loss on one.
UPDATE: Rhythm Pharmaceuticals (SYM: RYTM) Up 135%
- Dylan Jovine
- Thursday, July 14, 2022
A quick update and share some exciting news about one of our “Strong Buy” recommendations, Rhythm Pharmaceuticals (RYTM).
June 2021 Issue: Not all Obesity is the Same -Rhythm Pharmaceuticals
- Dylan Jovine
- Monday, June 21, 2021
Categories
Recent posts
Tags
Connect with Us
Get FREE Weekly Stock Tips
Join and receive market insider stock picks, trade alerts and unique investing insights
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
